Search research articles
Contact Us
Filters
Showing results (161-170 of 227) with videos related to
Page
of 23
Sort By:
Bone Marrow Transplantation
|
March 14, 2024
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany
Sandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, et al.
Infection
|
December 14, 2023
Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era
Veronika Götz, Philipp Mathé, Prerana Agarwal, et al.
Anticancer Research
|
May 18, 2012
Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma
Lisa Billecke, Eva Maria Murga Penas, Annette M May, et al.
Blood Cancer Journal
|
January 4, 2023
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Hira Mian, Arleigh McCurdy, Smith Giri, et al.
Haematologica
|
April 21, 2018
Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)
Johannes M Waldschmidt, Alexander Keller, Gabriele Ihorst, et al.
Annals of Hematology
|
December 4, 2022
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers
Benedikt Frank, Gabriele Ihorst, Georg Herget, et al.
The Oncologist
|
February 28, 2016
The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective
Jo Caers, Carlos Fernández de Larrea, Xavier Leleu, et al.
Haematologica
|
December 1, 2020
Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany
Monika Engelhardt, Khalid Shoumariyeh, Amelie Rösner, et al.
Haematologica
|
August 11, 2019
Phosphorylation of BECLIN-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia
Chuanjiang Yu, Sivahari P Gorantla, Alina Müller-Rudorf, et al.
Hemasphere
|
June 18, 2026
Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases
Alexander Carpinteiro, Christoph Kimmich, Despina Trajanova, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 227) with videos related to
Sort By:
Page
of 23
Bone Marrow Transplantation
|
March 14, 2024
Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation in patients with relapsed/refractory multiple myeloma in Germany
Sandra Sauer, Monika Engelhardt, Karolin Trautmann-Grill, et al.
Infection
|
December 14, 2023
Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era
Veronika Götz, Philipp Mathé, Prerana Agarwal, et al.
Anticancer Research
|
May 18, 2012
Similar incidences of TP53 deletions in extramedullary organ infiltrations, soft tissue and osteolyses of patients with multiple myeloma
Lisa Billecke, Eva Maria Murga Penas, Annette M May, et al.
Blood Cancer Journal
|
January 4, 2023
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
Hira Mian, Arleigh McCurdy, Smith Giri, et al.
Haematologica
|
April 21, 2018
Safety and efficacy of vorinostat, bortezomib, doxorubicin and dexamethasone in a phase I/II study for relapsed or refractory multiple myeloma (VERUMM study: vorinostat in elderly, relapsed and unfit multiple myeloma)
Johannes M Waldschmidt, Alexander Keller, Gabriele Ihorst, et al.
Annals of Hematology
|
December 4, 2022
Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers
Benedikt Frank, Gabriele Ihorst, Georg Herget, et al.
The Oncologist
|
February 28, 2016
The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective
Jo Caers, Carlos Fernández de Larrea, Xavier Leleu, et al.
Haematologica
|
December 1, 2020
Clinical characteristics and outcome of multiple myeloma patients with concomitant COVID-19 at Comprehensive Cancer Centers in Germany
Monika Engelhardt, Khalid Shoumariyeh, Amelie Rösner, et al.
Haematologica
|
August 11, 2019
Phosphorylation of BECLIN-1 by BCR-ABL suppresses autophagy in chronic myeloid leukemia
Chuanjiang Yu, Sivahari P Gorantla, Alina Müller-Rudorf, et al.
Hemasphere
|
June 18, 2026
Teclistamab in relapsed/refractory light chain amyloidosis: A retrospective multicenter study by the German Society for Amyloid Diseases
Alexander Carpinteiro, Christoph Kimmich, Despina Trajanova, et al.
Page
of 23